Madrigal Pharmaceuticals, Inc.: Positive opinion from Goldman Sachs







Marketzone with MT Newswires 2022

All the news about MADRIGAL PHARMACEUTICALS, INC.

Analyst Recommendations for MADRIGAL PHARMACEUTICALS, INC.

2022 turnover

2022 net result -274M

-270M
trso. net 2022 84.7M

83.4M
PER 2022-5.16x
2022 return
Capitalization 1,229M
1,229M
1,210M
VE / CA 2022
VE / CA 202328.6x
Number of employees71
Floating79.6%

Chart MADRIGAL PHARMACEUTICALS, INC.


Hard :

Period:




Madrigal Pharmaceuticals, Inc. : Madrigal Pharmaceuticals, Inc. Technical Analysis Chart |  Market area

Trends Technical Analysis MADRIGAL PHARMACEUTICALS, INC.

Short termMiddle termLong term
TrendsNeutralNeutralNeutral

Evolution of the Income Statement

Sale

Purchase

Average recommendationTO BUY
Number of Analysts13
Last Closing Price$79.51
Average price target$157.17
Deviation / Average Target97.7%

Officers and Directors




Source link -88